On April 1, 2026, Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has acquired View Point Medical, Inc. The aggregate transaction consideration, including the assumption of View Point liabilities, is approximately $140 million. Wilson Sonsini Goodrich & Rosati advised View Point on the transaction.

The acquisition—through which View Point became a wholly owned subsidiary of Merit—expands Merit’s portfolio of therapeutic oncology products dedicated to the accurate diagnosis and localization of breast and soft tissue tumors. View Point, located in Carlsbad, California, manufactures the OneMark® Detection Imaging System and OneMark Tissue Markers.

The Wilson Sonsini team that advised View Point on the transaction includes:

Corporate
Marty Waters
Jason Skolnik
Ben Capps
Karl Kobylecki
Brandon Shaw
Michael Coury

Employee Benefits and Compensation
Megan Schilling
Han Bae

Tax
Jonathan Zhu
Joy Cheng
Anjali Krishnan

Technology Transactions
Alex Key
Aleks Vitomirov

For more information, please see Merit’s news release.